Max Planck Institute
The Max Planck Society for the Advancement of Science was established in 1911 (then called the Kaiser Wilhelm Society). It is an independent non-governmental and non-profit association of German research institutes publicly funded by the federal and the 16 state governments of Germany. The Max Planck Society has a world-leading reputation as a science research organization, with 33 Nobel Prizes awarded to their scientists.
Max Planck Society participates with two different departments/institutes:
The Max Planck Institute of Molecular Plant Physiology (MPI-MP)
Max Planck Institute for Terrestrial Microbiology in Marburg, Germany (MPI-TM)
IN SRL is a small agency founded in 2008 whose mission is to support private and public organizations in participating to EU, national and local innovation projects and to provide professional project management services.
Presently the agency counts on several collaborations with small and large enterprises (mainly in the nanotechnology, and chemical sector, renewable biofuels), universities and research centers (nanotechnology, health, energy) all around Europe.
Imperial College London
The Imperial College London was founded in 1907 and has approximately 14,000 full-time students and 6,500 staff. It is a member of the so-called Russell group and consistently ranks high globally among higher education institutions. In the 2014 REF exercise, the Department of Life Sciences was ranked no. 1 in Biological Sciences, out of all UK Universities, in ‘Research Intensity’.
The Weizmann Institute of Science is one of the world’s leading multidisciplinary research institutions. The Institute has five faculties, Mathematics and Computer Science, Physics, Chemistry, Biochemistry and Biology, divided into 17 scientific departments. The Feinberg Graduate School, the Institute’s university arm, trains research students pursuing graduate degrees. The Weizmann Institute serves as a meeting place for scientists from different disciplines, setting the stage for multidisciplinary collaborations and the emergence of new research fields.
Evogene is a world leading plant genomics company, utilizing a proprietary technology infrastructure to enhance seed traits underlying crop productivity. The company was established on 2002, has been a public company since 2007 (TASE:EVGN), and in November 2011 completed a successful IPO in the US (NYSE:EVGN). Evogene offers a complete solution for crop productivity improvement through biotechnology, advanced breeding and chemical discovery.